Close Menu

HIV

A combination of pooled nucleic acid testing and social marketing improved early diagnosis of HIV infection in men who have sex with men in Vancouver, according to research published this week.

Tasso, a two-year-old startup focused on point-of-care, blood-based diagnostics, has been awarded a Phase I Small Business Innovation Research grant from the National Institutes of Health to develop a sample preparation and stabilization device for use with HIV viral load quantif

Researchers at the Gladstone Institutes and the University of California, San Francisco are evaluating next-generation sequencing for its ability to detect early signs of drug resistance in HIV patients.

Integrated Diagnostics said this week that it has spun out its protein catalyzed capture agent business into a new firm, InDi Molecular.

NEW YORK (GenomeWeb News) – A team of clinical researchers in Vancouver has received C$5 million (US$4.8 million) in new funding to use next-generation sequencing to improve methods for testing for drug resistance in HIV/AIDS patients, Genome British Columbia said today.

Alere President and CEO Ron Zwanziger last week provided investors with an update on the development timeline for a pair of point-of-care nucleic acid testing plartforms, the company's first molecular diagnostics products.

NEW YORK (GenomeWeb News) – Microbial communities in the human gut shift in response to HIV infection-related changes in intestinal immunity and inflammation, potentially reinforcing and contributing to some of these symptoms, a new study suggests.

NEW YORK (GenomeWeb News) – MBio Diagnostics today said that it has achieved ISO 13485:2003 certification for its quality management system.

NEW YORK (GenomeWeb News) – Case Western Reserve University said today that it has licensed exclusive worldwide rights to University Hospitals Case Medical Center to a series of HIV diagnostic tests.

Calimmune has become the latest RNAi drug developer to move into the clinic, recently initiating a phase I/II trial of its HIV therapy Cal-1.

Pages

The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.

Researchers have sequenced the genome of "the Methuselah of freshwater fish."

The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.